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Abstract
Background: Glutamate-induced excitotoxicity, oxidative damage, and neuroinflammation are believed to play an
important role in the development of a number of CNS disorders. We recently reported that a high dose of glutamate
could induce AMPK-mediated neurodegeneration in the postnatal day 7 (PND7) rat brain. Yet, the mechanism
of glutamate-induced oxidative stress and neuroinflammation in the postnatal brain is not well understood.
Here, we report for the first time the mechanism of glutamate-induced oxidative damage, neuroinflammation,
and neuroprotection by polyphenolic anthocyanins in PND7.
Methods: PND7 rat brains, SH-SY5Y, and BV2 cells treated either alone with glutamate or in combination
with anthocyanins and compound C were examined with Western blot and immunofluorescence techniques.
Additionally, reactive oxygen species (ROS) assay and other ELISA kit assays were employed to know the
therapeutic efficacy of anthocyanins against glutamate.
Results: A single injection of glutamate to developing rats significantly increased brain glutamate levels, activated and
phosphorylated AMPK induction, and inhibited nuclear factor-E2-related factor 2 (Nrf2) after 2, 3, and 4 h in a time-
dependent manner. In contrast, anthocyanin co-treatment significantly reduced glutamate-induced AMPK induction,
ROS production, neuroinflammation, and neurodegeneration in the developing rat brain. Most importantly, anthocyanins
increased glutathione (GSH and GSSG) levels and stimulated the endogenous antioxidant system, including Nrf2 and
heme oxygenase-1 (HO-1), against glutamate-induced oxidative stress. Interestingly, blocking AMPK with compound C in
young rats abolished glutamate-induced neurotoxicity. Similarly, all these experiments were replicated in SH-SY5Y cells
by silencing AMPK with siRNA, which suggests that AMPK is the key mediator in glutamate-induced neurotoxicity.
Conclusions: Here, we report for the first time that anthocyanins can potentially decrease glutamate-induced
neurotoxicity in young rats. Our work demonstrates that glutamate is toxic to the developing rat brain and that
anthocyanins can minimize the severity of glutamate-induced neurotoxicity in an AMPK-dependent manner.
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Background
The central nervous system (CNS) is comprised of
several neurotransmitter receptors, with glutamate re-
ceptors being one of the major excitatory neurotransmit-
ter receptors that have multiple functions, such as
neuronal plasticity, outgrowth, and survival, as well as
memory, learning, and behavior [1]. Conversely, glutam-
ate release is under the control of various glutamate
transporters as exposure to elevated levels is harmful to
neurons. The overstimulation of postsynaptic glutamate
receptors causes neuronal injury/death, which is termed
as glutamate excitotoxicity as is believed to be involved
in amyotrophic lateral sclerosis (ALS) and several other
CNS disorders [2–4]. This glutamate excitotoxicity is
believed to arise specifically from the entrance of a high
rate of Ca2+ into the neurons as a result of over-
stimulated postsynaptic glutamate receptors [5]. The
excess amount of intracellular Ca2+ levels can increase
the burden of mitochondrial Ca2+, thereby inducing
mitochondrial damage and reactive oxygen species
(ROS) generation in the mitochondria [6–8]. Overpro-
duction of ROS is thought to cause a diversity of
diseases. There is a sophisticated antioxidant defense
mechanism in cells that aides in coping with ROS levels
under normal physiological conditions, but under certain
conditions, such as excessive ROS and inflammation,
excessive Ca2+ can cause cellular dysfunction and re-
modeling [9, 10].
NF-E2-related factor 2 (Nrf2) is a transcription factor
that is bound to the antioxidant response element (ARE)
and can induce the regulation of various antioxidant en-
coding genes, particularly heme oxygenase-1 (HO-1)
[11]. Previous reports have proven that the activation of
Nrf2 in cells and tissues in response to oxidative stress
protects against oxidative injury. Under normal condi-
tions, Nrf2 is localized in the cytoplasm [12], while
under oxidative stress conditions, it translocates into the
nucleus and transactivates its target genes through ARE.
Various protein kinases have been reported to be
involved in the ARE-mediated gene Nrf2 activation in
response to the oxidative stress signals including 5′
AMP-activated protein kinase (AMPK) [13]. AMPK pri-
marily functions as an energy sensor [14]. AMPK activa-
tion not only suppresses ATP-consuming metabolic
pathways but also accelerates the energy-producing
signaling pathways to offer cellular protection against
any stress.
Natural polyphenolic compounds that are obtained
from fruits and vegetables have received a great deal of
interest during the last decade, due to their potential to
inhibit oxidative stress, as reported in various studies
[15]. Anthocyanins are a group of natural phenolic
compounds that confer the different colors of plants
and fruits. Evidence suggests that anthocyanins are
strong natural antioxidants [16, 17]. Our research
group has recently reported the anti-apoptotic, anti-
oxidant, and anti-obesity effects of Korean black
bean-derived anthocyanins in different experimental
models [18–22].
In the current study, we extended our line of investiga-
tion to elucidate the exact mechanism of the neuroprotec-
tion of Korean black bean-derived anthocyanins against
glutamate-induced excitotoxicity, oxidative stress, neuro-
inflammation, and neurodegeneration in the hippocampus
of the developing rat brain and in SH-SY5Y and BV2 cells.
Methods
Animals and drug treatment
Sprague-Dawley (SD) rat pups (18-g average body
weight) on postnatal day 7 (n = 5 rats/group) were ran-
domly divided into the following eight groups (the treat-
ment outlines are given in Additional file 1):
1. Control (C)
2. Glutamate for 2 h (Glu 2 h)
3. Glutamate for 3 h (Glu 3 h)
4. Glutamate for 4 h (Glu 4 h)
5. Glutamate for 4 h + anthocyanins (Glu 4 h + Anth)
6. Glutamate for 4 h + compound C (Glu 4 h + CC)
7. Glutamate for 4 h + compound C + anthocyanins
(Glu 4 h + CC + Anth)
8. Anthocyanins (Anth)
Glutamate (10 mg/kg), anthocyanins (100 mg/kg),
and compound C (10 mg/kg) [23] in saline solution
were intraperitoneally (i.p.) injected. Glutamate was
administered for 2, 3, or 4 h. The control animals
received 0.9 % saline solution, and all the rats were
decapitated after 2, 3, or 4–12 h. All the experimental
procedures were approved by local ethical committee
for animals of the Department of Biology, Division of
Applied Life Sciences, Gyeongsang National University
South Korea.
Cell culturing and drug treatment
Murine BV2 microglia and human neuroblastoma SH-
SY5Y cells were maintained in 10 % FBS- and 1 % peni-
cillin/streptomycin-supplemented DMEM (Dulbecco’s
modified Eagle’s medium) medium in a humidified 5 %
CO2 incubator at 37 °C. The cells were treated with
glutamate (30 mM), glutamate plus anthocyanins
(30 mM + 20 μg/ml), glutamate plus AMPK siRNA
(30 mM + 200 nM), glutamate plus AMPK siRNA plus
anthocyanins (30 mM + 200 nM + 20 μg/ml), glutamate
plus compound C (30 mM + 20 μM), and glutamate
plus compound C and anthocyanins (30 mM + 20 μM
+ 20 μg/ml) for 3 h.
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AMPK gene silencing
Small interfering RNA (siRNA) was purchased from
Santa Cruz Biotechnology (sc-45312). Cultured SH-
SY5Y cells were transfected with 200 nM siRNA using
Lipofectamine 2000 reagent (Invitrogen) for 24 h [24],
then the DMEM medium was replaced with glutamate




razolium bromide) assay was performed according to
the manufacturer’s instructions (Sigma) to assess the
SH-SY5Y cell viability after treatment. The cells were
cultured in 96-well plates at a density of 1 × 104 cells per
well containing 100 μl DMEM. When the cells were
attached after 24 h, the medium was refreshed with the
indicated concentration of glutamate (10, 20, and
30 mM) and anthocyanins (10, 20, and 30 μg/ml), while
control cells received only DMEM medium. The cells
were then incubated for an additional 3 h. After being
cultured for 3 h, the cells were incubated with MTT so-
lution for another 4 h at 37 °C. Subsequently, the
medium was replaced with DMSO in each well. Finally,
the absorbance was measured at 570 nm. All experi-
ments were performed independently in triplicate.
Western blot analysis
Western blot analysis details were conducted as previ-
ously performed in our lab [25]. Briefly, the animals
were euthanized after 4 h following treatment of glutam-
ate with or without anthocyanins. Then, the brains were
carefully (hippocampus) collected and placed on dry ice
for freezing tissue. Similarly, after treatment, the SH-
SY5Y and BV2 cells were collected in PBS and centri-
fuged, and the supernatant was removed. The remaining
pellet was dissolved in Pro Prep Protein Extraction Solu-
tion, according to the manufacturer’s protocol (iNtRON
Biotechnology) to make cell lysates. The brain homoge-
nates and cell lysates were quantified with Bio-Rad pro-
tein assay solution. The homogenates (20 μg protein)
were fractionated by SDS-PAGE on 4–12 % (Bolt™ Mini
Gels, Life Technologies). After transfer, membranes were
blocked in 5 % skim milk (or BSA) and incubated over-
night at 4 °C with primary antibody, and cross-reacting
proteins were detected by ECL after reaction with horse-
radish peroxidase-conjugated secondary antibodies. The
primary antibodies (1: 500 in Tris-buffered saline with
Tween (TBST)) included rabbit-derived anti-COX2,
anti-TNFα, anti-p-AMPKTh172, anti-AMPK, anti-Nrf2,
anti-caspase-3, anti-iNOS, anti-p-NF-kB, mouse-derived
anti-β-actin, anti-GFAP, anti-heme oxygenase-1 (HO-1),
and goat-derived anti-Iba-1 from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA). After using membrane-
derived secondary antibodies (1: 1000 in TBST), ECL
(Amersham Pharmacia Biotech, Uppsala, Sweden) detec-
tion reagent was used for visualization according to the
manufacturer’s instructions. Densitometry analysis of the
bands was performed using Sigma Gel software (SPSS,
Chicago, IL, USA). Density values were calculated in ar-
bitrary units (A.U.) relative to the untreated control.
Tissue collection and sample preparation
The animals were euthanized after 12 h of drug treat-
ment to conduct morphological studies as we reported
earlier [26]. Briefly, the brain tissues from all the treated
groups after 12 h were subjected to transcardial perfusion
with 4 % ice-cold paraformaldehyde. After postfixing these
brain tissues, 4 % paraformaldehyde was transferred to
20 % sucrose. The tissues were frozen in OCT (Tissue-
Tek O.C.T. Compound Medium, Sakura Finetek USA,
Inc., Torrance, CA, USA), sectioned into 14–16-μm sec-
tions in the coronal plane with a CM 3050S cryostat
(Leica, Wetzlar, Germany). The sections were thaw-
mounted on Probe-On positively charged slides (Thermo
Fisher Scientific Inc., Waltham, MA, USA).
Fluoro-Jade B staining
Fluoro-Jade B staining was performed as reported earlier
[27]. Chamber slides were air-dried overnight. The slides
were kept in a solution of 80 % ethanol and 1 % sodium
hydroxide then in 70 % alcohol for 5 and 2 min, respect-
ively, followed by immersion in distilled water for 2 min.
The slides were placed for 10 min in 0.06 % potassium
permanganate solution. The slides were then rinsed with
distilled water and immersed in a solution containing
0.1 % acetic acid and 0.01 % Fluoro-Jade B for 20 min.
After rinsing with distilled water and applying DAPI, the
slides were dried, and glass cover slips were mounted on
slides with mounting medium. Images were captured
using an FITC filter on a confocal laser scanning micro-
scope (FV 1000, Olympus, Japan).
Immunofluorescence
Immunofluorescence stainings were performed as we
previously reported [19]. Shortly, the slides were
washed with 1× PBS and incubated with proteinase K
solution at room temperature. After blocking in normal
goat/rabbit serum, primary antibodies (1: 100 in PBS,
mentioned in the “Western blotting” section) were ap-
plied overnight at 4 °C. Fluorescence-based (FITC and
TRITC from Santa Cruz Biotechnology) secondary anti-
bodies (in PBS) were applied at room temperature.
DAPI was used to stain the nucleus. The slides were
mounted with glass coverslips, and the images were
taken using a confocal microscope (FluoView FV 1000;
Olympus, Tokyo, Japan).
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TUNEL staining
To determine apoptotic cell death, TUNEL (terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP
nick-end labeling) staining was performed according to
the manufacturer’s recommendations. An in situ cell
death detection kit was purchased from Roche (Cat. No.
11684809910).
Oxidative stress (ROS) detection in vivo and in vitro
The ROS quantification assay in the brain homogenates
of all treated groups was conducted as reported earlier
in the literature and by our research group [28, 29] with
slight modification. Briefly, the brain homogenates from
the respective groups were diluted 1:20 times with
Locke’s buffer (ice-cold) to get 5 mg tissue/ml concen-
tration. Then, the reaction mixture (1 ml) having Locke’s
buffer of pH 7.4, 0.2 ml brain homogenate, and 10 ml of
DCFH-DA (5 mM) was incubated for 15 min at room
temperature to allow the DCFH-DA to be incorporated
into any membrane-bound vesicles and the diacetate
group cleaved by esterases. After 30 min of further incu-
bation, the conversion of DCFH-DA to the fluorescent
product DCF was measured using a spectrofluorometer
with excitation at 484 nm and emission at 530 nm. ROS
formation was quantified from a DCF-standard curve
and data are expressed as pmol DCF formed/min/mg
protein. Similarly, an in vitro ROS assay was performed
with slight modification as previously described [26].
Briefly; SH-SY5Y cells were sub-cultured in 96-well
plates in 200 μl DMEM that was supplemented with
10 % FBS and 1 % penicillin/streptomycin in every well.
The cells were incubated for 24 h at 37 °C in a humidi-
fied incubator having 5 % CO2. The next day, the media
was replaced by fresh media that contained Glu
(30 mM), Glu plus anthocyanins (30 mM+ 20 μg/ml),
Glu plus compound C (30 mM+ 20 μM), or Glu plus
compound C and anthocyanins (30 mM+ 20 μM+
20 μg/ml) for an additional 30 min. DCFDA (2′,7′-
dichlorofluorescin diacetate) 600 μM dissolved in
DMSO/PBS was added to each well and incubated for
30 min. The plates were then read in ApoTox-Glo™
(Promega) at 488/530 nm.
Glutamate assay
Glutamate assay kit (Cat. # KA1670) from Abnova
(Taipei, Taiwan) was used to quantify glutamate in hip-
pocampal brain tissue homogenates according to the
manufacturer’s instruction.
Enzyme assays
The hippocampal rat brain homogenates and SH-SY5Y
cell lysates of the experimental groups were evaluated
using ELISA assays for total NF-kBp65 (Life Technolo-
gies, Catalog #KHO0371) and Cyclex AMPK (Enzo Life
Sciences), as per the manufacturer’s recommended
protocols.
COX2 assay
An ELISA assay for COX2 (R&D Systems, Inc. 614
McKinley Place NE Minneapolis, MN 55413, USA) was
performed. BV2 and SH-SY5Y cells were sub-cultured in
96-well plates, and treatment was performed in differ-
ent groups, as described earlier, and then fixed with
4 % paraformaldehyde, as per the manufacturer’s
recommendations.
GSH assays
The levels of total GSH and GSH/GSSG ratio were deter-
mined by using glutathione assay kit obtained from BioVi-
sion (BioVision Incorporated155 S. Milpitas Boulevard,
Milpitas, CA 95035, USA), Fluorometric Assay Kit
(Catalog #K264-100), according to the manufacturer’s
instructions.
Statistical analysis
A computer-based Sigma Gel System (SPSS Inc.,
Chicago, IL) and the ImageJ program were used to
analyze the density and integral optical density (IOD) of
scanned X-ray films of Western blot and immunofluor-
escence images. Density values were expressed as the
mean ± SEM. All data are presented as the mean ± SEM.
A one-way ANOVA followed by Student’s t test (non-
parametric Mann-Whitney and Wilcoxon tests) were
used to determine the statistical significance (P < 0.05) of
the obtained data.
Results
Exogenous glutamate induced multiple neurotoxic effects
in the developing rat brain in a time-dependent manner
The brain glutamate level was analyzed with a glutam-
ate assay kit method in developing brain homogenates
after exogenous glutamate administration. Our results
(Fig. 1a) indicated that exogenous glutamate produced
significant up-regulation of brain glutamate in the
hippocampus of young rats after 2, 3, and 4 h (where
4 h was the most significant increase in glutamate level)
following its administration in a time-dependent man-
ner. Similarly, glutamate also induced the activities of
AMPK and NF-kBp65 in the same manner within 2 to
4 h, as assessed with the help of a respective ELISA
assay kit method (Fig. 1b, c). We then examined the
protein expression level of AMPAR, phosphorylated
AMPKTh172 (p-AMPK), Nrf2, and phosphorylated nu-
clear factor kappa (p-NF-kB) in the hippocampal brain
homogenates of the developing brain in a time-
dependent manner. The results (Fig. 1d) indicate that
exogenous glutamate administered to the developing
rats significantly increased the expression level of
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AMPARs, p-AMPK, and p-NF-kB after 2, 3, and 4 h in
the hippocampus (whereas after 5 h, glutamate level
and its toxic effects began to decline and that data is
not shown here). Similarly, this glutamate also caused
the inhibition of hippocampal Nrf2 proteins in a time-
dependent manner (Fig. 1d).
Anthocyanins are beneficial against glutamate-induced
neurotoxicity in the developing brain
We then evaluated the therapeutic efficacy of anthocya-
nins against glutamate-induced neurotoxicity in the
developing rat brain. As shown above, it was observed
that exogenous glutamate could cause a maximal up-
a
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Fig. 1 Glutamate increased brain glutamate level, AMPK activation, and Nrf2 inhibition in a time-dependent manner in the hippocampal CA1
region of the developing rodent brain. a Brain glutamate level, b AMPK activity, and c total NF-kBp65 activity analysis using ELISA histograms in
the CA1 region brain homogenates after glutamate administration in a time-dependent manner. d The immunoblot protein expressions of
AMPAR, phospho-AMPK, total AMPK, Nrf2, and β-actin in the developing rat brain homogenates 2, 3, and 4 h following glutamate administration.
Relative density histograms depict the differences across the groups. Representative blots obtained in sections were prepared from at least five
animals per group. Relative histograms of e brain glutamate level, f AMPK activity, and g total NF-kBp65 in the CA1 region brain homogenates of
experimental groups, including glutamate and anthocyanins with or without glutamate treated P7 rats after 4 h. These assays were conducted in triplicate
with similar results according to the manufacturer instructions. Significance, *P< 0.05, **P< 0.01, and ***P< 0.001 and ##P< 0.01, respectively
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regulation of hippocampal brain glutamate levels as well
as AMPK and NF-kBp65 activities 4 h after its adminis-
tration. For this reason, we co-treated rat pups with an-
thocyanins along with glutamate. Anthocyanin treatment
significantly reduced brain hippocampal glutamate levels
as well as AMPK and NF-kB activities against exogen-
ously injected glutamate (Fig. 1e–g). Similarly, Western
blot results revealed that anthocyanin administration
also significantly down-regulated glutamate-induced
AMPA receptor expression and p-AMPK activation in
the developing rat brain (Fig. 2a). Immunofluorescence
investigation of p-AMPK also supported our Western
blot results that indicated that anthocyanins could
reduce glutamate-induced AMPK activation in the
hippocampal CA1 region (Fig. 2b). Additionally, the ex-
ogenously administered glutamate also increased the
intracellular calcium abundance by upregulating the ex-
pression level of CaMKII protein, which was accompanied
Fig. 2 Beneficial effects of anthocyanins on glutamate-induced excitotoxicity in the developing rodent brain. a The immunoblots of AMPAR, p-
AMPK, p-AMPA, and CaMKII proteins along with their relative density histograms in the experimental groups. β-Actin was used as a loading
control. b The immunostaining images and respective relative IOD histogram of p-AMPK protein in the CA1 region of young rats that were
treated with glutamate with or without anthocyanins. The images show p-AMPK (green) and DAPI (blue) color. c The Western blot results of Nrf2
and HO-1 proteins in the brain homogenates of P7 rats. The significant differences among the different treated groups are indicated by relative
density histograms. The bands were quantified with sigma gel software and density histograms (expressed in arbitrary units, i.e., A.U.) relative to
control were made with Prism GraphPad. d The immunofluorescence investigation of Nrf2 in the CA1 section of developing rats after glutamate
and anthocyanin administration. The tissues were post-fixed in 4 % paraformaldehyde and 20 % sucrose solution for 72 h. The immunofluorescence
staining techniques are given in the “Methods” section. e The histogram indicates the relative ROS contents in the different experimental groups. CA1
rat brain homogenates were prepared according to the protocol of the ROS assay, as cited in the manuscript. The assay was repeated for three times
with the same results. Significance, **P < 0.01 and ***P < 0.001 and ##P < 0.01 and ###P < 0.001, respectively
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by AMPA receptor phosphorylation at Ser845 (i.e., p-
AMPA Ser845); however, the rat pups that received antho-
cyanins as a co-treatment significantly inhibited the
glutamate-induced up-regulation of CaMKII and p-
AMPA Ser845 protein expression, as shown in Fig. 2a.
Anthocyanins increased cellular glutathione levels and
activated the Nrf2/HO-1 signaling pathway against
glutamate-induced oxidative stress in the developing brain
To examine the antioxidant effect of anthocyanins, we
first analyzed glutathione (GSH and GSSG) levels ac-
companied by the quantification of the expression of
Nrf2 protein and its downstream signaling gene heme
oxygenase-1 (HO-1) with immunoblotting. Our results
show that glutamate treatment after 4 h significantly re-
duced cellular GSH content and GSH/GSSG ratio com-
pared with the saline-treated control in the developing
rat brain (Additional file 1: Fig. S1). Anthocyanins treat-
ment significantly increased cellular GSH content and
GSH/GSSG ratio against glutamate (Additional file 1:
Fig. S1). Similarly, we have already shown that exogen-
ously administered glutamate can significantly suppress
Nrf2 after 4 h (Fig. 1d). For this reason, the rat pups that
received anthocyanins with or without glutamate were
euthanized after 4 h and their brain homogenates were
subjected to Western blotting and a ROS assay. The
Western blot results revealed that anthocyanin treat-
ment significantly increased the expression of Nrf2 and
HO-1 proteins in the developing brain. Additionally, the
immunofluorescence examination of Nrf2 protein in
brain tissue agreed with our immunoblot results and
showed that anthocyanin treatment increased the ex-
pression of Nrf2 (in the nucleus, as shown Additional
file 1) in the hippocampal CA1 region of the developing
rat brain (Fig. 2c, d, the high magnification expanded
image is given in Additional file 1). Glutamate has been
reported for its ability to produce ROS. For this reason,
the ROS assay was conducted with the brain homoge-
nates of the experimental groups. The assay results indi-
cated that anthocyanin treatment significantly inhibited
glutamate-induced ROS production in the developing
rat brain (Fig. 2e).
Anthocyanins attenuated glutamate-induced
neuroinflammation and neurodegeneration
The extent of neuroinflammation that was induced by glu-
tamate was assessed with immunofluorescence, Western
blot, and ELISA assays. A single episode of glutamate in-
jection caused significant induction of glial cell activation,
including both astrocytes (GFAP) and microglia (Iba-1)
(Fig. 3a, b), which was accompanied by upregulated proin-
flammatory p-NF-kB and its downstream signaling mole-
cules, such as cyclooxygenase-2 (COX-2), tumor necrosis
factor-ά (TNF-ά), and caspase-3 protein expressions in
the hippocampal CA1 region of the developing rat brain
(Fig. 3c). Anthocyanin supplementation significantly at-
tenuated not only glutamate-induced glial cells activation
but also markedly inhibited p-NF-kB, COX-2, and
caspase-3 protein expression, as assessed with immuno-
fluorescence and Western blotting methods. The activity
histogram of NF-kBp65 (total), which was examined with
the ELISA methods, is also in agreement with the immu-
noblot results that anthocyanins can inhibit p-NF-kB ac-
tivity in the developing brain (Fig. 3d). Additionally,
glutamate-induced neurodegeneration in the immature
rodent brain was assessed with TUNEL staining. The re-
sults revealed that glutamate was able to induce significant
DNA fragmentation in the hippocampal CA1 region of
the developing rodent brain. In contrast, anthocyanin
treatment significantly decreased glutamate-induced
DNA fragmentation in the CA1 region of the P7 rodent
brain (Fig. 3e).
Glutamate-induced neurotoxicity is AMPK dependent in
the developing rat brain
To determine whether glutamate-induced neurotoxicity is
AMPK dependent, we injected compound C, an inhibitor
of AMPK, along with glutamate or without anthocyanins
into immature rats. Interestingly, compound C adminis-
tration significantly reduced glutamate-induced AMPK
activation, as shown in Fig. 4a, b. These results show that
compound C after 4 h blocked AMPK protein expression
(Fig. 4a) as well as activity (Fig. 4b), as indicated by
Western blot and ELISA assay, respectively. Accordingly,
the ROS assay that was conducted also supports the
notion that glutamate-induced ROS can activate AMPK,
as compound C has no effect on the ability of either
glutamate-induced oxidative stress or anthocyanins to re-
duce ROS in the developing brain (Fig. 4c). We measured
Nrf2 and HO-1 proteins levels using Western blot ana-
lysis. The immunoblot quantification revealed that com-
pound C significantly blocked the ability of glutamate to
suppress Nrf2 and HO-1 in the developing rat brain
(Fig. 4d). Similarly, compound C also blocked glutam-
ate from significantly activating p-NF-kB (both its ac-
tivity and expression), COX2, and caspase-3 proteins in
the hippocampus of the young rat brain (Fig. 4d, e). Inter-
estingly, compound C treatment affected the ability of an-
thocyanins to up-regulate Nrf2, HO-1, p-NF-kB, COX2,
and caspase-3 proteins (Fig. 4a, d, e). This suggests that in
the postnatal rat brain, glutamate produces its neurotox-
icity by activating AMPK.
Anthocyanins enhanced cell viability and decreased
glutamate-induced neurodegeneration in vitro
The MTT assay was conducted to measure the cell via-
bility of SH-SY5Y cells after treatment with different
concentrations of glutamate and anthocyanins. The
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Fig. 3 Anthocyanins reduced glutamate-induced glial cell activation, neuroinflammation, and DNA damage in hippocampal CA1 region of the
developing rat brain. Given are representative immunofluorescence images along with relative IOD histograms of a astrocytes (GFAP)-positive
cells and b microglia (Iba-1)-positive cells in the CA1 region of experimental groups. Images represent immunostaining performed with tissue
sections prepared from at least five rats in each group. Panels representing hippocampal CA1 region immunostained with GFAP (green), Iba-1(red)
counterstained with DAPI (blue) of young rat brain. c The immunoblot represents proinflammatory markers, including p-NF-kB, COX2 and TNF-α
proteins, which are accompanied by their relative density histograms. d The ELISA histogram of NF-kBp65 (total) in the brain homogenates of
treated animals. The assay was repeated three times according to the manufacturer’s instruction. e The extent of DNA damage in the CA1 region
by glutamate was analyzed by conducting TUNEL assay. To quantify DNA damage, ImageJ and Prism GraphPad programs were used. The values
represent the mean ± SEM for the indicated proteins (n = 5 animals per group). Significance, ***P < 0.001 and ##P < 0.01 and ###P <0.001, respectively
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Fig. 4 (See legend on next page.)
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results show that anthocyanins in three different concen-
trations (i.e., 10, 20, and 30 μg/ml) were non-toxic to
cells (Fig. 5a), in contrast to that of glutamate in three
concentrations (i.e., 10, 20, and 30 mM), which signifi-
cantly reduced SH-SY5Y cell viability (Fig. 5b). Similarly,
all three different concentrations of anthocyanins signifi-
cantly increased SH-SY5Y cell viability against glutamate
(30 mM), as shown in Fig. 5c. Additionally, the extent of
glutamate-induced neuronal loss was measured through
Fluoro-Jade B (FJB) staining in SH-SY5Y cells. The FJB
results indicated that glutamate (30 mM) significantly
induced neuronal apoptosis in SH-SY5Y cells, as shown
in Fig. 5d. Similarly, these images also revealed that an-
thocyanins (20 μg/ml) reduced the extent of neuronal
apoptosis in vitro (Fig. 5d).
Glutamate-induced neurotoxicity in vitro is AMPK
dependent
The mechanism of action of glutamate in vitro was con-
firmed by conducting experiments with SH-SY5Y and
BV2 cells. We first silenced AMPK with its siRNA and
then analyzed the expression levels of different proteins.
The results showed that the anthocyanin treatment sig-
nificantly reduced p-AMPK immunoreactivity (Fig. 5e)
and AMPK activity (Fig. 5f ) against glutamate in SH-
SY5Y cells. Similarly, anthocyanin treatment also re-
duced glutamate-increased p-AMPK protein expression,
as shown in Fig. 5g. Additionally, anthocyanins en-
hanced Nrf2 and HO-1 expression, which are antagonis-
tic towards the effects of excessive glutamate, in vitro
(Fig. 5g). The expressions levels of Nrf2 were measured
both with immunoblotting and immunofluorescence
methods (Fig. 5g, h). AMPK was silenced with its
siRNA, which not only decreased p-AMPK activity but
also reduced its expression (Fig. 5f, g). Interestingly, the
effect of anthocyanins on the expressions level of p-
AMPK, Nrf2, and HO-1 was also observed following
siRNA-mediated AMPK silencing (Fig. 5f ). Similarly, the
ROS assay that was conducted revealed that anthocya-
nins significantly inhibited glutamate-induced ROS pro-
duction in cells. Again, compound C was observed to
have no effect on ROS generation, thereby supporting
our in vivo results that this ROS is independent of
AMPK in vitro as well (Fig. 5i).
We then measured the expression level of p-NF-kB,
COX2 and caspase-3 after treating with glutamate and
anthocyanins with or without AMPK siRNA-treated SH-
SY5Y cells. Again, anthocyanins significantly reduced the
expression level of p-NF-kB, COX2 and caspase-3; how-
ever, AMPK knock-down completely blocked the ability
of glutamate to up-regulate the abovementioned proin-
flammatory and apoptotic marker in SH-SY5Y cells
(Fig. 6a). The silencing of AMPK also affected the in-
hibitory potential of anthocyanins. Similarly, the activ-
ities of NF-kB and COX2, as measured by ELISA kit
methods, also supported the notion that glutamate-
induced NF-kB and COX2 activity up-regulation was
AMPK dependent (Fig. 6b, c).
We also used BV2 cells to examine the beneficial ef-
fects of anthocyanins against glutamate-induced cytotox-
icity. The double immunofluorescence results indicated
that anthocyanins reduced the expression levels of p-
AMPK and p-NF-kB against glutamate in BV2 cells
(Fig. 6d). Similarly, anthocyanin treatment enhanced
Nrf2 immunoreactivity in the nucleus of BV2 cells
(Fig. 6e). Additionally, we analyzed the activity of COX2
by blocking AMPK with compound C in vitro and meas-
uring activity via an ELISA kit. The results showed that
anthocyanin treatment decreased glutamate-induced
COX2 activity (Fig. 6f ). Compound C treatment dimin-
ished the ability of glutamate to induce an increase in
COX2 activity and reduced anthocyanins ability to in-
hibit COX2 activity in BV2 cells, which indicates that
this process is dependent upon AMPK (Fig. 6f ). All
these events in the current study are highlighted in
detail in the Fig. 7.
Discussion
The current study demonstrates several important find-
ings (as shown in detail in Fig. 7). First, it reports that
exogenously administered glutamate in the developing
rat can increase brain glutamate levels as well as activate
and phosphorylate AMPK and NF-kB, which is accom-
panied by Nrf2 protein inhibition. These toxic effects
(See figure on previous page.)
Fig. 4 Glutamate-induced neurotoxicity in the developing rodent brain is AMPK dependent. a The expression level of p-AMPK, Nrf2, and HO-1
proteins in the P7 rat brain homogenates that were treated with glutamate or glutamate with or without compound C and anthocyanins for 4 h.
Their densities were measured with the help of Sigma Gel software. Their respective relative density histograms were made with Prism GraphPad. The
membranes were redeveloped for β-actin and used as a loading control. b, c The histograms of AMPK activity and ROS assay were conducted with
brain homogenates of the abovementioned experimental animal groups. The assays were performed in triplicate with the same results. d The Western
blot analysis of p-NF-kB, COX2, and caspase-3 proteins in the hippocampus of postnatal day 7 rat brain following treatment with glutamate, glutamate
and compound C, or glutamate, compound C, and anthocyanins. The relative integrated density for the abovementioned proteins are depicted in the
histograms. The density values are expressed in arbitrary units as the mean ± SEM for the indicated proteins (n = 5 animals per group). Details are
provided in the “Methods” section. e The activity histogram of NF-kBp65 (total) in the brain homogenates of treated animal’s measured with ELISA kit
method. Significance; ***P < 0.001 and ###P < 0.001, respectively











Fig. 5 (See legend on next page.)
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that were induced by glutamate were observed following
2, 3, and 4 h of its administration, as measured and
quantified by Western blot and ELISA assays. Those re-
sults indicate that glutamate can induce a maximal toxic
effect after 4 h when compared to 2 and 3 h. Second,
this study provides evidence that after 4 h, anthocyanins
can reduce brain glutamate levels, AMPK activation,
ROS production, and inflammation. Third, anthocyanins
increased glutathione levels and stimulated Nrf2/HO-1
signaling, which has an important role in cellular
defense against oxidants and toxic chemicals. Finally, we
reported that blocking AMPK either with compound C
or with siRNA not only negatively regulates glutamate-
induced AMPK activation and inflammation but also
can abolish the neuroprotective abilities of anthocyanins
in young rats as well as in SH-SY5Y cells.
AMPK and oxidative stress have long been associated
with neurodegenerative diseases. Oxidative stress dis-
rupts mitochondrial respiration and damages mitochon-
dria, which ultimately induce apoptotic cell death and
degeneration [30]. Mitochondria, a major regulator of
apoptosis, have an important role in controlling cell life
and death [31]. Current findings indicate that anthocya-
nins decrease glutamate-induced ROS and energy reduc-
tion, thereby protecting against oxidative stress.
Here, for the first time, we found that AMPK signaling
mediates a crucial role in the antioxidant activity of an-
thocyanins against glutamate-induced oxidative stress.
This beneficial effect of anthocyanins, both in young rats
and in cells, is associated with up-regulation of glutathi-
one (both GSH levels and GSSG ratio) and the stimula-
tion of Nrf2/HO-1 as an important antioxidant-signaling
pathway. Our findings demonstrated that anthocyanins
both inhibited glutamate-upregulated proinflammatory
and neuroapoptotic markers as well as suppressed
endogenous antioxidant molecules via activated AMPK
reduction. Recently, anthocyanins have been shown to
exert AMPK-mediated neuroprotection against kainic
acid-induced excitotoxicity in cells [22]. Anthocyanins
are comprised of various flavonoids that have been re-
ported to have beneficial effects against oxidative stress,
inflammation, and neurodegeneration [32–34]. These
beneficial effects of anthocyanins are due to their antiox-
idative characteristics, as demonstrated by several re-
searchers in their reports [16, 17]. Similarly, numerous
studies have indicated that cyanidin-3-O-glucoside
(C3G), one of the active components of anthocyanins, is
a potent neuroprotective agent against cerebral ischemia
and β-amyloid-induced mitochondrial damage [35, 36]
and can block the release of apoptosis-inducing factor
(AIF) in focal cerebral ischemia [37]. The blueberry-
enriched diet has been shown to reduce kainic acid-
induced oxidative stress and excitotoxicity mediated
memory impairment [38].
Oxidative stress is one of the earliest pathological
changes in neurodegenerative diseases such as Alzheimer’s
disease (AD). The hippocampus and cortex sections of the
brain are vulnerable to oxidative stress and are associated
with the development of cognitive impairment as a feature
of sporadic AD. Similarly, another risk factor for AD is
aging, in which the endogenous system is unable to scav-
enge free radicals and ultimately produces oxidative stress
in the brain [39]. Additionally, the brain has a relatively
weak antioxidant defense system compared to other or-
gans of the body and so the activation of the endogenous
antioxidant system is particularly vital for those tissues. In
this regard, the stimulation of Nrf2-ARE signaling path-
ways in the brain has been considered as one of the major
pharmaceutical strategies for the treatment and preven-
tion of neurodegenerative disease and brain aging. Nrf2 is
believed to be involved in regulating phase II antioxidant
responses, which induce the activation of several free rad-
ical scavengers and beneficial enzymes. HO-1 is one of the
important genes in the brain and is activated by Nrf2, as
demonstrated by intensive studies that have a crucial role
in providing shelter to neurons against cell death. Accord-
ingly, numerous reports have described that Nrf2 activa-
tion [40, 41] induces an increase in HO-1 in response to
(See figure on previous page.)
Fig. 5 The beneficial effects of anthocyanins against glutamate-induced toxicity in SH-SY5Y cells. a–c The cell viability histograms of SH-SY5Y cells,
as indicated by the MTT assay. a The cells were incubated with three different (indicated) concentrations of anthocyanins for 24 h. b The cell
viability histogram of SH-SY5Y cells that were treated with the indicated concentrations of glutamate for 3 h. c The cell viability histogram after
pretreating cells (12 h) with three concentrations of anthocyanins and glutamate (30 mM) for additional 3 h. All details are provided in the
“Methods” section. d The immunofluorescence images and respective relative IOD histogram of FJB (green)-positive and DAPI (blue) SH-SY5Y cells.
Cells were grown in four-well chamber slides and then treated with the mentioned (“Methods” section) concentrations of glutamate and anthocyanins.
The FJB staining was repeated in triplicate. e The immunostained images of p-AMPK (green) protein counterstained with DAPI (blue) in the SH-SY5Y
cells. The panels represent different treating groups such as untreated control, glutamate, or glutamate and anthocyanins. f The histogram of relative
AMPK activity assay conducted with cell lysate experimental treating groups having siRNA of AMPK. g The Western blot analysis of p-AMPK, Nrf2, and
HO-1 protein expressions and their relative density histograms after treating cells with glutamate and glutamate and anthocyanins and in the presence
or absence of AMPK siRNA. h The immunostaining images and respective relative IOD histograms of Nrf2 protein in SH-SY5Y cells. i The ROS assay
histogram after treating SH-SY5Y cells with glutamate or glutamate and anthocyanins with or without compound C. The groups and other experimental
details are provided in the “Methods” section. Significance, *P< 0.05, **P < 0.01, ***P < 0.001 and ##P < 0.01 and ###P <0.001, respectively
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several neurodegenerative disorders [42]. Many studies
have shown that HO-1 activation is an important response
to the threat of oxidative stress to neurons as it can rescue
neurons from oxidative stress and cell death [43, 44]. HO-
1 has been strongly linked to reduced inflammation [45].
Similarly, HO-1 knockout mice have been shown to de-
velop inflammatory disease and are sensitive to experi-
mental sepsis [46], while the pharmacological activation of
HO-1 has been found to be beneficial in the inflammation
animal model [47]. Excessive glutamate that is triggered
by oxidative stress or ROS accumulation induces neuronal
apoptosis and cell death. This process is similar in nature
to numerous neurodegenerative diseases and some patho-
logical conditions, such as ischemia and trauma [3, 48, 49].
The literature has shown that glutamate can induce Nrf2







Fig. 6 Glutamate-induced toxicity in SH-SY5Y and BV2 cells is AMPK dependent. a The Western blot analysis and relative integrated density
histograms of p-NF-kB, COX2 and caspase-3 proteins in SH-SY5Y cells. The treatment details are the same as described in the “Methods” section.
β-Actin was used as a loading control. b The activity histogram of NF-kBp65 (total) in the cell lysates, as measured with an ELISA kit. c The COX2
assay was performed with SH-SY5Y cells after treatment with the indicated concentrations of glutamate, anthocyanins, and compound C for the
indicated duration of time. After treatment, cells were fixed prior to performing the assay as per the manufacturer’s instructions. The immunostaining
images (d) of p-NF-kB (green), p-AMPK (red) (e), Nrf2 (green) and DAPI (blue) in the BV2 cells treated with glutamate and anthocyanins. Their densities
are depicted in the relative IOD histogram. f The COX2 assay histogram in BV2 cells was conducted according to the manufacturer’s instructions.
Significance, ***P < 0.001 and ##P < 0.01, ###P < 0.001, respectively
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of inflammation and neurodegeneration in the postnatal
brain as well as in cells. In the present study, we have dem-
onstrated that a single dose of exogenously provided glu-
tamate caused the induction of neuroinflammation and
neurodegeneration in the postnatal rat brain. Additionally,
glutamate treatment in SH-SY5Y and BV2 cells also in-
duced the activation of proinflammatory and proapoptotic
markers, such as NF-kB and caspase-3 expression. As per
our results, these toxic effects of glutamate are AMPK
dependent because our findings indicate that either com-
pound C or siRNA-mediated silencing of AMPK can di-
minish the toxic effects of glutamate treatment both in
vivo and in vitro.
Although some additional work is necessary to elucidate
the mechanisms that are involved in this current network,
the findings from this study have identified a major role of
AMPK activation by anthocyanins in the attenuation of
oxidative stress through the activation of Nrf2/HO-1 sig-
naling. Furthermore, our study suggests that anthocyanins
might be a pharmacological therapeutic agent for use in
combination with other potential drugs in the treatment
of various neurodegenerative diseases.
Conclusions
Our data demonstrate that glutamate could induce its
neurotoxicity within 2–3 h in AMPK-dependent manner
in the developing rat’s brain. Similarly, we report for the
first time that the ability of anthocyanins to reverse
glutamate-suppressed Nrf2/HO-1 is AMPK dependent
in young rats. This study demonstrates that anthocyanin
is a highly potent agent in vivo and in vitro against
glutamate-induced oxidative stress and neurodegenera-
tion as it have attractive drug-like properties.
Additional file
Additional file 1: Figure S1. Anthocyanin upregulated glutathione
levels (GSH and GSH/GSSG ratio) against glutamate in the developing rat
brain. The histograms show (a) the levels of total Glutathione (GSH) and
(b) the ratio of GSH/GSSG in the brain homogenates of rat pups 4 h after
glutamate and anthocyanin treatment. All the procedures were followed
as provided by the manufacturer. These assays were performed in
triplicate with the same results. Significance, **P < 0.001 and ##P < 0.001,
respectively. Figure S2d. (PDF 189 kb)
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